NetScientific plc (NSCI) ORD GBP0.05
NetScientific PLC is a United Kingdom-based healthcare intellectual property (IP) commercialization company. The Company is focused on technologies and companies that treats chronic disease and improve the health and well-being. The Company funds, develops, and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in United States and Europe with a primary focus on digital health, diagnostics and therapeutics. The Company is an investor providing management support, including technical guidance, administrative support, IP and commercial knowhow. The Company has investments in approximately 15 portfolio companies in the United States, United Kingdom and Israel in industrial high-tech, energy and healthcare. The Company’s subsidiaries include NetScientific UK Limited, NetScientific America, Inc and Glycotest, Inc.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.